This study raises several methodological and statistical concerns that may affect its validity. Key issues include the lack of justification for the selected potassium humate dosages, potential inconsistencies in data—particularly in disease incidence and blood parameters—and misrepresentation of cited studies. Additionally, the absence of raw data for verification and a possible conflict of interest raise transparency concerns. Could the authors clarify these issues to ensure the integrity and clarity of their findings?
The clarify the raised concerns: The selection of potassium humate dosages (0.5–2%) appears to lack explicit justification, and it would be beneficial to confirm whether these were based on prior research, preliminary trials, or industry recommendations. Regarding potential inconsistencies in disease incidence and blood parameters, all measurements appear to follow standard protocols, and any observed variations seem to align with expected biological responses, though further clarification from the authors would be helpful. The cited studies generally support the discussion. If my understanding of these concerns is incorrect, I welcome any corrections.